<DOC>
	<DOC>NCT03010280</DOC>
	<brief_summary>A prospective randomized clinical trial of all the patients undergoing Roux - en-Y gastric bypass will be performed. Patients will be randomly assigned into 2 groups: those patients receiving a preoperative balanced energy high-protein formula (group 1) and those receiving preoperative Immunonutrition (group 2). Preoperative weight loss, postoperative septic complications and analytical acute phase reactants will be investigated.</brief_summary>
	<brief_title>Effect of Immunonutrition on Septic Complications After Roux-en-Y Gastric Bypass</brief_title>
	<detailed_description>A prospective randomized clinical trial of all the patients undergoing Roux - en-Y gastric bypass will be performed. Patients will be randomly assigned into 2 groups: those patients receiving a preoperative balanced energy high-protein formula (group 1) and those receiving preoperative Immunonutrition (group 2). Postoperative septic complications (anastomotic leak and organ/space SSI) and analytical acute phase reactants (white blood cell count and C reactive protein) will be investigated.</detailed_description>
	<mesh_term>Postoperative Complications</mesh_term>
	<criteria>body mass index (BMI)&gt;40 kg/m2 BMI&gt;35 kg/m2 with the presence of comorbidities associated to obesity Patients undergoing RouxenY gastric bypass as bariatric procedure Patients undergoing other bariatric techniques different than RouxenY gastric bypass gastroesophageal reflux patients with uncontrolled psychiatric disorders active infections or malignancies any other concomitant pathology considered as a contraindication for bariatric surgery.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>